Type 2 diabetes mellitus (T2DM) is associated with an increased risk of fractures according to several studies. The underlying mechanisms remain unclear, although small case-control studies indicate poor quality of the cortical bone. We have studied a population-based sample of women aged 75 to 80 years in Gothenburg, randomly invited from the population register. Areal bone mineral density (aBMD) was measured by dual-energy X-ray absorptiometry (Hologic Discovery A), bone microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT; ExtremeCT from Scanco Medical AG), and reference point indentation was performed with Osteoprobe (Active Life Scientific). Women with T2DM (n ¼ 99) had higher aBMD compared to controls (n ¼ 954). Ultradistal tibial and radial trabecular bone volume fraction (þ11% and þ15%, respectively), distal cortical volumetric BMD (þ1.6% and þ1.7%), cortical area (þ11.5% and þ9.3%), and failure load (þ7.7% and þ12.9%) were higher in diabetics than in controls. Cortical porosity was lower (mean AE SD: 1.5% AE 1.1% versus 2.0% AE 1.7%, p ¼ 0.001) in T2DM in the distal radius but not in the ultradistal radius or the tibia. Adjustment for covariates (age, body mass index, glucocorticoid treatment, smoking, physical activity, calcium intake, bone-active drugs) eliminated the differences in aBMD but not in HR-pQCT bone variables. However, bone material strength index (BMSi) by reference point indentation was lower in T2DM (74.6 AE 7.6 versus 78.2 AE 7.5, p < 0.01), also after adjustment, and women with T2DM performed clearly worse in measures of physical function (one leg standing: -26%, 30-s chair-stand test: -7%, timed up and go: þ12%, walking speed: þ8%; p < 0.05-0.001) compared to controls. In conclusion, we observed a more favorable bone microarchitecture but no difference in adjusted aBMD in elderly women with T2DM in the population compared to nondiabetics. Reduced BMSi and impaired physical function may explain the increased fracture risk in T2DM.
Introduction
E pidemiologic studies have shown that type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporotic fractures, (1, 2) especially hip fractures according to a meta-analysis. (3) The increased fracture risk in T2DM may seem paradoxical, because areal bone mineral density (aBMD) is higher in subjects with T2DM than in controls in many studies. (4) In general, subjects with T2DM have a higher than normal body weight and body mass index (BMI) but after adjustment for BMI, aBMD has also been reported as increased compared to healthy subjects. (5) Furthermore, at a given aBMD, subjects with T2DM have a higher risk of fracture than the normal population. (6) This has led to the conclusion that other factors, both skeletal and nonskeletal, contribute to the increased risk of fracture in T2DM. (7) (8) (9) In addition to low aBMD, deteriorated bone microarchitecture has for long been considered to contribute to the increased risk of fractures in osteoporosis. (10) In a few relatively small case-control studies, cortical bone microarchitecture has been studied in patients with T2DM. Some studies have shown no difference in microarchitecture, (11, 12) whereas others have found that T2DM with fractures compared to T2DM without fractures (13, 14) or T2DM compared to controls (15) (16) (17) had worse cortical bone microstructure. Furthermore, bone material strength index (BMSi) measured by reference point indentation in vivo of the cortical bone in the tibia has been reported as reduced in T2DM. (12, 18) It has been suggested that advanced glycosylation endproducts (AGEs) and microvascular complications could interfere with normal bone metabolism and contribute to poorer bone quality in T2DM. (18, 19) In addition, nonskeletal factors such as diabetic complications, physical disability, and increased risk of falls have been suggested to contribute to the increased risk of fractures in T2DM. (20) (21) (22) Previous studies characterizing the skeletal phenotype in T2DM have mainly included small groups of patients with diabetes attending tertiary clinics, and the control groups have in most studies been equally small, not allowing for adjustment for confounding factors known to influence BMD and bone strength. (11) (12) (13) (14) (15) (16) (17) (18) We have performed a population-based study on women between 75 and 80 years of age with and without T2DM with regard to aBMD, bone microarchitecture, BMSi, and physical function, in order to further characterize the bone phenotype in T2DM.
Subjects and Methods

Subjects
This study is a cross-sectional study on an initial sample of 1057 women from a prospective population-based study that was performed in the greater Gothenburg area and included a total of 3030 ambulant women aged 75 to 80 years, randomly recruited via the Swedish national population register between the years 2013 to 2016. The subjects first received an invitation letter, and were then contacted by telephone. Those who accepted and were eligible to participate (were ambulant and able to follow instructions in Swedish, and had at least one hip that could be evaluated for aBMD) were scheduled for a visit (42.7%). All examinations took place at the Osteoporosis Clinic, Department of Geriatrics, Sahlgrenska University Hospital, M€ olndal, Sweden.
Among the 1057 women in the present study, four had type 1 diabetes mellitus and were excluded from all analyses. A total of 74 women had known T2DM and received pharmacological treatment with metformin (n ¼ 61), insulin (n ¼ 18), repaglinide (n ¼ 6), sulfonylureas (n ¼ 6), sitagliptin (n ¼ 2), exenatide (n ¼ 1), and pioglitazone (n ¼ 1). Of these 74 women a total of 53 had monotherapy for T2DM, 40 with metformin and nine with insulin. Twenty-five women were newly diagnosed with T2DM, and either had fasting plasma glucose above 7 mmol/L or nonfasting plasma glucose above 11 mmol/L, resulting in a group of 99 women with T2DM and 954 control subjects. The study protocol was approved by the ethical review board at the University of Gothenburg and all subjects signed an informed consent prior to participation.
Anthropometrics and physical function tests
Body height and weight were measured twice using standardized equipment and the mean values were used in the analyses. If there was more than 5 mm difference between the height measurements, a third measure was obtained and the two most similar values were used. BMI was calculated by dividing weight in kilograms with the squared height measurement in meters.
Physical function was evaluated by several tests. Timed Up and Go (TUG) is a combined measure of mobility and balance (23) and was performed by asking the women to rise from a sitting position, walk 3 m, turn around, walk back, and sit down again.
The number of seconds to complete the test was recorded. In the 30-s chair-stand test, the women were asked to rise from the chair with their arms crossed over their chest and sit down again as many times as possible during 30 s. This test is a measure of lower body strength in older adults (24) and the number of complete movements from starting to rise to getting back to the sitting position was assessed. One leg standing test is a clinical balance test (25) and was performed twice for both legs after trying the test position once. The test position was to look straight ahead, have the arms crossed over the chest, and lift the lower leg back by bending the knee. The maximum time allowed was 30 s, the women were allowed to choose which leg to start with, and the highest value was used in the analyses. Grip strength was measured with a Saehan hydraulic hand dynamometer (model SH5001; Saehan Corporation, Masan, Korea) with two attempts for each hand while the lower arm rested on a flat surface and the elbow was at a 90-degree angle. An average for the dominant hand was used in the analyses. For the 10-m walk test, the women were asked to walk 10 m twice at a pace of their own choice. In order to eliminate the effects of acceleration and deceleration, the middle 6 m was timed and average walking velocity in m/s was calculated and used in the analyses.
Questionnaires
Information on medical history, medication and life-style factors influencing the risk for osteoporosis and fractures was obtained by a standardized questionnaire that was filled out by all women. Physical Activity Scale for the Elderly (PASE) was used to estimate the physical activity the last 7 days prior to assessment, and a score was calculated from participation and the number of hours per week spent in each activity multiplied by given weights and summarized. (26) Daily calcium intake was estimated by combining the amount of calcium provided by supplements with food-derived calcium intake estimated by a validated questionnaire. (27) Dual-energy X-ray absorptiometry Dual-energy X-ray absorptiometry (DXA) was used for assessment of aBMD and body composition. The same device was used for all subjects (Hologic Discovery A; Hologic, Waltham, MA, USA) and the BMD measurements were performed at the femoral neck, total hip and lumbar spine (L 1 -L 4 ). A total body scan was used to assess the amount of fat and lean body mass. The coefficient of variation (CV) for women in this age group at our unit was 1.3% for the femoral neck, 0.8% for the total hip, and 0.7% for the lumbar spine.
HR-pQCT
High-resolution peripheral quantitative computed tomography (HR-pQCT) of the tibia and radius of the nondominant body side was performed using XtremeCT (Scanco Medical AG, Br€ uttisellen, Switzerland) in accordance with a previously described protocol. (28) All participants were measured at the standard site with the first image 9.5 and 22.5 mm from a line placed at the articular plateau in the radius and tibia, respectively ( Fig. 1A) . A more proximal section located at 14% of the bone length was also measured ( Fig. 2A) , providing a site with mainly cortical bone. A total of 110 cross-sectional images were obtained at both the standard and the 14% site as described. (29) Quality of the images was estimated in accordance with the protocol from the manufacturers (30) and graded on a scale from 1 (best) to 5 (worst). Only scans with adequate quality (1 to 3) were used in the analyses. Volumetric bone mineral density (vBMD) and bone microarchitecture estimates were assessed from both the standard and the more proximal 14% site. CVs were calculated from measurements of six women between 75 and 80 years of age who were scanned twice at our unit.
Trabecular variables (trabecular bone volume fraction [BV/TV], number [Tb.N], thickness [Tb.Th], and separation [Tb.Th]) were analyzed as described (31, 32) at the standard site where trabecular bone is abundant (Fig. 1 ). The CVs of the trabecular variables in the tibia were 0.8% for BV/TV, 1.9% for Tb.N, 2.6% for Tb.Th, and 2.1% for Tb.Sp.
Cortical variables were analyzed at both the standard and the 14% site using Image Processing Language (IPL v5.08b) provided by the manufacturer (Scanco Medical AG) to further process all images. (33) To delineate the bone from extra-osteal soft tissue and to separate cortical from trabecular bone, contours were automatically placed at the periosteal and endosteal sides of the cortical bone. These contours were manually corrected after careful inspection, if needed. Within the two contours, cortical vBMD and microarchitecture were assessed. Cortical bone volume (Ct.BV), cortical vBMD, and cortical area were measured, and cortical porosity was calculated as Ct.Po.V/(Ct.Po.V þ Ct.BV). (33, 34) The CV for cortical porosity in the tibia was 0.9% at the standard site and 4.1% at the 14% site. CVs for measurement of cortical vBMD and cortical area were 0.3% and 0.7%, respectively, at the 14% site.
Finite element (FE) analysis (FEA) was performed with models created with software from Scanco Medical AG (version V5.11/ FE-V01.15), by converting the voxels to brick elements of the same size. A simulated uniaxial compression was applied and failure load was estimated as the load at which at least 2% of the bone elements surpassed 7000 microstrain. (35, 36) Stiffness, the resistance against deformation, was also reported. A Young's modulus of 10 GPa and a Poisson ratio of 0.3 were used in the FE models for all subjects, in accordance with a previously described method. (35) The CVs for these measurements ranged from 0.5% to 1.5% in the radius and 0.6% to 1.2% in the tibia. 
Bone microindentation
A total of 477 women (45.1%) also accepted to undergo bone microindentation.
Reference point indentation was performed with an Osteoprobe device (Active Life Scientific, Santa Barbara, CA, USA) in accordance with the instructions from the manufacturer and as described (29, 37) in order to obtain estimates of BMSi. In brief, after local anesthesia, the needle of the Osteoprobe was inserted through the skin and periosteum of the anterior mid-tibia. A preload force of up to 10 N was applied to establish the probe and an impact force of 30 N was released by a trigger mechanism. The distance the probe moved in the cortical bone from the established position after release of the impact force, the indentation distance increase, was related to the distance the probe moved in a polymethylmethacrylate plastic calibration phantom and multiplied by 100 in order to obtain the BMSi for the individual patient. At least 10 valid microindentations were related to the mean of five indentations in the polymethylmethacrylate phantom for each study subject. The CV for BMSi in elderly women at our unit was 3.2%.
Vertebral fracture assessment
Vertebral fracture assessment (VFA) was performed using lateral scans by DXA and the semiquantitative classification of Genant. (38) One physician (LJ) evaluated all scans and graded the fractures as mild, moderate, or severe according to the height reduction of the vertebrae. The reproducibility was tested as previously reported (39) and the intraobserver agreement was 98.9% (kappa score 0.72) for all fractures and 100% (kappa score 1.0) for moderate and severe fractures.
Statistical analyses
Statistical comparison between subjects with and without T2DM was done with independent t tests for continuous variables and with x 2 for categorical variables. Multivariable linear regression was used to adjust bone variables for covariates (age, BMI, previous and present glucocorticoid treatment, smoking, physical activity assessed by PASE, daily calcium intake, and bone-specific medication). Values are presented as mean AE SDs unless otherwise stated and p values less than 0.05 were considered significant. All statistical analyses were performed with SPSS Statistics Version 21 (IBM Corporation, Armonk, NY, USA).
Results
The characteristics of the women with and without T2DM in the population-based sample are presented in Table 1 . The women with T2DM had a higher body weight (þ13%) and BMI (þ14%) than the controls (p < 0.001 for both comparisons). Both fat and lean body mass was higher in T2DM (Table 1 ). There was a tendency toward lower current physical activity as measured by 
Journal of Bone and Mineral Research
PASE in the women with T2DM than in controls (98 AE 55 versus 108 AE 53, p ¼ 0.072). More women with T2DM had been diagnosed with hypertension (76% versus 49%, p < 0.001) and there was no difference between the groups in the number of women who were treated with bone-active drugs (in total: oral bisphosphonates, n ¼ 60; intravenous bisphosphonates, n ¼ 1; denosumab, n ¼ 1) or glucocorticoids or who were current or previous smokers. Three percent of the women with T2DM were treated with bone-active drugs and 6% of the controls (not significant). There was no difference in the self-reported number of falls during the last year, vertebral fractures according to VFA, or fractures after 50 years of age (Table 1 ). Mean duration of T2DM was 10.8 AE 6.2 years (median, 10 years; range, 2 to 25 years). aBMD aBMD measured by DXA of the femoral neck, total hip, and lumbar spine (L 1 -L 4 ) was 4.5% to 8.6% higher in women with T2DM than in controls (Table 2 ). However, after adjustment for covariates the differences in aBMD between the groups were not statistically significant ( Table 2) .
Bone microarchitecture and vBMD
The trabecular bone volume fraction of both radius and tibia was significantly higher in subjects with T2DM compared to controls (þ15%, and þ11%, respectively, p < 0.001 for both comparisons), also after adjustment for covariates ( Table 2 , Fig. 3A ). Cortical porosity of the radius was higher in subjects with T2DM at the standard site (þ16%, p < 0.01), but lower at the 14% site (-25%, p 0.001) whereas there were no differences in cortical porosity in the tibia at either site, neither before nor after adjustment for covariates (Table 3) . There was a close correlation between trabecular BV/TV and cortical porosity at the standard site both at the radius (r ¼ 0.28, p ¼ 0.000) and at the tibia (r ¼ 0.19, p ¼ 0.000).
The correlation between trabecular BV/TV and cortical porosity was clearly lower at the more proximal 14% site (r ¼ 0.07, p ¼ 0.049 at 14% of the radius; r ¼ 0.07, p ¼ 0.046 at 14% of the tibia). Adjustment for the variation in trabecular BV/TV eliminated the difference in cortical porosity at the standard site of the radius (adjusted values 4.0% AE 2.0% for T2DM and 3.7% AE 1.6% for controls, p ¼ 0.14). Representative images from the standard and the 14% site of subjects with and without T2DM are shown in Figs. 1B-C and 2B-C. Also the other trabecular and cortical variables indicated better microarchitecture in subjects with T2DM than in controls both before and after adjustment for covariates (Tables  2-3 
Bone material strength and FE analysis
BMSi was clearly lower in subjects with T2DM compared to controls (74.6 AE 7.6 versus 78.2 AE 7.5, p 0.001) also after adjustment for covariates ( Fig. 5 ). Stiffness and failure load were significantly higher in the subjects with T2DM than in controls at both sites of the radius both before and after adjustment for covariates. At the standard site of the tibia, women with T2DM had significantly higher stiffness and failure load before, but not after, adjustment (Table 3 ). However, the measurement at the 14% site resulted in significantly higher stiffness and failure load in the tibia also after adjustment ( Table 3 ). Further adjustment, also for BMSi by linear regression, attenuated the differences in stiffness (T2DM 71 AE 9 kN/mm versus controls 68 AE 10 kN/mm, p ¼ 0.13) and failure load (T2DM 3521 AE 445 N versus controls 3416 AE 521 N, p ¼ 0.24) at the 14% site of the radius but did not significantly alter any other results (data not shown).
Tests of physical function
The women with T2DM performed worse than controls in most physical function tests, including the one-leg standing test Values are means AE SD. Unadjusted p values were obtained by statistical comparison between T2DM and controls by independent samples t tests. Adjusted p values were from comparison of values obtained by linear regression adjusting for age, body mass index, previous and present glucocorticoid treatment, current and previous smoking, physical activity according to physical activity scale for the elderly (PASE), daily calcium intake, and bone-specific medication (bisphosphonates and denosumab).
BMD ¼ bone mineral density; T2DM ¼ type 2 diabetes mellitus; DXA ¼ dual-energy X-ray absorptiometry; HR-pQCT ¼ high-resolution peripheral quantitative computed tomography; BV/TV ¼ bone volume fraction. 
Discussion
In our study, the diagnosis of T2DM in ambulant elderly women from the population was associated with better bone microarchitecture but worse physical function and reduced bone material strength. This is of interest as there are numerous reports on higher risk for fractures in T2DM, (1) (2) (3) 6) and because this is the largest cohort of T2DM with the most comprehensive bone phenotype characterization by HR-pQCT and microindentation so far in the literature.
Some of the previous smaller studies, (15) (16) (17) but not all, (11, 12) have described increased cortical porosity in T2DM and the main hypothesis has been that the increased fracture rate in T2DM is mainly due to impaired cortical bone quality. Cortical porosity has previously been shown to be associated with prevalent fractures (40) and correlated to bone strength. (41) Our finding of a higher cortical porosity at the standard site of the radius in T2DM could be explained by higher trabecular bone volume fraction in T2DM, causing a misplacement of the endosteal contour. The cortical evaluation is more reliable at a more proximal measuring site, as the risk of misplacing the endosteal contour in the analysis is lower, especially in elderly subjects who have thin cortices. (42) Because of the relatively high positive intercorrelation at the standard site between trabecular bone volume fraction and cortical porosity, we speculate that the estimate of cortical porosity can be compromised in areas with thin cortices and high bone volume fraction in the trabecular bone due to difficulties of defining the border between trabecular and cortical bone. The correlation between trabecular bone volume fraction and cortical porosity was substantially weaker at the 14% site, indicating that assessment of porosity at that site provides a more accurate measurement. Furthermore, as the variation in bone length introduces a systematic error in the estimation of cortical porosity (43) and other HR-pQCT-derived bone variables, the use of a measure that relates to bone length such as the 14% site is likely to provide more accurate measurements. Based upon these issues we propose that evaluating cortical porosity is more accurate at a more proximal site measured at a distance relative to bone length. By using such a measurement we observed a lower cortical porosity at the 14% site of the radius and no difference in the tibia between T2DM and controls, arguing against higher cortical porosity in T2DM. This is also congruent with the observation of normal or higher values in other bone microarchitecture variables in T2DM. However, differences in skeletal traits between measuring sites could not be ruled out. Both the standard and 14% sites are in close vicinity of the most common location of a typical forearm fracture (44) and could therefore be of interest to measure in order to predict these fractures. One other study included a more proximal, fixed, site to evaluate cortical porosity in T2DM, (13) but was without a comparison to a relevant control group as patients with T2DM with and without fractures were compared. As expected, patients who had sustained a fracture, regardless of a concomitant diagnosis of T2DM, had higher Values are means AE SD. Unadjusted p values were obtained by statistical comparison between T2DM and controls by independent samples t tests. Adjusted p values were from comparison of values obtained by linear regression adjusting for age, body mass index, previous and present glucocorticoid treatment, current and previous smoking, physical activity according to physical activity scale for the elderly (PASE), daily calcium intake, and bone-specific medication (bisphosphonates and denosumab).
BMD ¼ bone mineral density; HR-pQCT ¼ high-resolution peripheral quantitative computed tomography; T2DM ¼ type 2 diabetes mellitus. cortical porosity than subjects without fractures but there was no comparison between fracture patients with and without T2DM. (13) In a relatively large Danish study, aBMD and bone microarchitecture were compared between type 1 diabetes mellitus (T1DM) and T2DM patients attending university clinics. (45) In comparison, subjects with T2DM had higher T-scores for hip, femur, and spine aBMD, higher tissue stiffness in the tibia, and higher cortical pore volume in the radius compared to T1DM. Previous studies have reported a higher risk of fractures in T1DM than in T2DM, (4) indicating that the causes for bone fragility may be partly different in these diagnoses. Hyperglycemia and hypoglycemia, accumulation of AGEs, type of pharmacological therapy, and vascular complications are all factors that may influence bone health in diabetes mellitus. (46) (47) (48) The pathogenesis for bone disease is likely to be multifactorial, especially in T2DM, and therefore difficult to elucidate in small studies, because lifestyle factors such as inactivity and obesity are well known to contribute both to the development of T2DM and to the risk of fracture. (49) In contrast to the more favorable cortical and trabecular microstructure, subjects with T2DM performed worse in physical function tests including TUG, rising from a chair, and walking speed. These tests are relatively easy to perform and have been shown to reflect physical function of importance for the daily life in the elderly. (23) (24) (25) A slower TUG test has been reported to be an independent predictor of fracture risk in older women. (50) Previous studies have also shown that the risk of falling is increased in T2DM. (21) Poor physical function may be secondary to low physical activity that may contribute both to the development of T2DM and osteoporosis. However, current physical activity was included in our adjusted comparisons and a better bone microarchitecture was still seen in T2DM.
Bone material strength measurement in vivo by microindentation is a relatively new method. Previous studies have shown differences between fracture patients and controls, and the effects of different bone-active drugs in glucocorticoidtreated subjects. (37, 51) In the latter study, there was detectable change in BMSi already after 7 weeks. BMSi is correlated to bone toughness in some (52) but not all (53) experimental studies. Previous smaller studies in subjects with T2DM have shown lower values compared to controls (12, 18) and our study confirms this in a larger population-based study. However, because it is unknown how the BMSi translates to the clinical risk for fracture, the importance of this finding remains unclear.
Among the limitations of our study is that it only includes ambulant women and there is a risk that there is a selection of relatively fit T2DM patients in our study. This may be the reason for not finding a difference in fracture rate, and for the high quality of bone microarchitecture in T2DM. There was, however, a clear reduction both in BMSi and in physical function in T2DM that could indicate a higher risk of fracture. Among the strengths of our study are the high number of subjects with T2DM with detailed bone phenotype and its population-based design with a large control group. Thus, in our view, it can be used for conclusions regarding bone phenotype in ambulant women aged 75 to 80 years of age with T2DM.
In conclusion, our results confirm that areal BMD is not reduced whereas BMSi is lower in T2DM. However, trabecular and cortical microarchitecture as well as biomechanical properties by FEA was clearly better in this large group of women with T2DM compared to a population-based control group, whereas different measures of physical function were clearly worse. We therefore suggest that a significant proportion of the increased fracture risk in T2DM depends on physical impairment and perhaps on reduced bone material strength. It remains to be shown if improved physical function can reduce the risk of fractures in T2DM.
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